Zhangwei Tong

441 total citations
17 papers, 347 citations indexed

About

Zhangwei Tong is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zhangwei Tong has authored 17 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Zhangwei Tong's work include Estrogen and related hormone effects (4 papers), RNA Research and Splicing (4 papers) and Cancer-related Molecular Pathways (3 papers). Zhangwei Tong is often cited by papers focused on Estrogen and related hormone effects (4 papers), RNA Research and Splicing (4 papers) and Cancer-related Molecular Pathways (3 papers). Zhangwei Tong collaborates with scholars based in China, United States and United Kingdom. Zhangwei Tong's co-authors include Chundong Yu, Kesong Peng, Jianming Xu, Wengang Li, Mengzhen Li, Pingli Mo, Yonghong Liu, Bing Shen, Liping Qin and Jun Yan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Zhangwei Tong

16 papers receiving 347 citations

Peers

Zhangwei Tong

ONCOL

GENET

IMMUN

Deyang Li China

Wei Wen China

Guo‐Qing Tao China

Shufeng Ji China

Binbin Cui China

Zhonghai Guan China

Jeannette Huaman United States

Yaozhen Pan China

Feiye Liu China

Yirui Yin China

Deyang Li China

Zhangwei Tong

204 ×0.9

110 ×1.0

52 ×0.6

ONCOL

20 ×0.4

GENET

43 ×1.0

IMMUN

Citations per year, relative to Zhangwei Tong Zhangwei Tong (= 1×) peers Deyang Li

Countries citing papers authored by Zhangwei Tong

Since Specialization

Citations

This map shows the geographic impact of Zhangwei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangwei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangwei Tong more than expected).

Fields of papers citing papers by Zhangwei Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhangwei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangwei Tong. The network helps show where Zhangwei Tong may publish in the future.

Co-authorship network of co-authors of Zhangwei Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhangwei Tong. A scholar is included among the top collaborators of Zhangwei Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhangwei Tong. Zhangwei Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tong, Zhangwei, Yong Zhang, Peng Guo, et al.. (2024). Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP‐9. Journal of Cellular and Molecular Medicine. 28(7). e18171–e18171. 4 indexed citations

Zhang, Zhao, et al.. (2023). Wide refractive index detection range sensors based on D-shape photonic crystal fiber with a nanoscale gold wire. Optik. 292. 171409–171409. 3 indexed citations

Yu, Xiaobin, Tao He, Zhangwei Tong, et al.. (2023). Molecular mechanisms of TWIST1‐regulated transcription in EMT and cancer metastasis. EMBO Reports. 24(11). e56902–e56902. 27 indexed citations

Chen, Qiang, Kesong Peng, Junjia Liu, et al.. (2022). Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling. Oncogene. 41(20). 2846–2859. 19 indexed citations

Chen, Xiaoqiang, et al.. (2022). PolyC-RNA-binding protein 1 (PCBP1) enhances tropomyosin 3 (TPM3) mRNA stability to promote the progression of esophageal squamous cell carcinoma. Bioengineered. 13(4). 8581–8592. 7 indexed citations

Lee, Dong-Kee, Zhangwei Tong, Xiaobin Yu, et al.. (2021). Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype. Proceedings of the National Academy of Sciences. 118(21). 8 indexed citations

Tong, Zhangwei, et al.. (2020). Platinum versus immunotherapy for unresectable esophageal cancer. Medicine. 99(51). e23537–e23537. 1 indexed citations

Tong, Zhangwei, et al.. (2020). Platinum versus immunotherapy for early resectable non-small cell lung cancer. Medicine. 99(43). e22349–e22349.

Zhang, Zhenyang, et al.. (2020). Long intergenic non‐coding RNA Linc00485 promotes lung cancer progression by modulating miR‐298/c‐Myc axis. Journal of Cellular and Molecular Medicine. 25(1). 309–322. 6 indexed citations

10.

Tong, Zhangwei, et al.. (2019). The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer–promoter interactions. Journal of Biological Chemistry. 294(51). 19667–19682. 11 indexed citations

11.

Peng, Kesong, Mengzhen Li, Liping Qin, et al.. (2017). Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α. Oncogene. 36(27). 3868–3877. 90 indexed citations

12.

Chen, Wenbo, Yuan Chen, Ming Li, et al.. (2017). Steroid Receptor Coactivator 3 Contributes to Host Defense against Enteric Bacteria by Recruiting Neutrophils via Upregulation of CXCL2 Expression. The Journal of Immunology. 198(4). 1606–1615. 13 indexed citations

13.

Tong, Zhangwei, Kesong Peng, Wei Wang, et al.. (2016). Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expression. Cell & Bioscience. 6(1). 47–47. 43 indexed citations

14.

Li, Ming, Wei Wang, Zhangwei Tong, et al.. (2016). Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinoma. Oncotarget. 7(20). 29605–29619. 8 indexed citations

15.

Tong, Zhangwei, Ming Li, Wei Wang, et al.. (2015). Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling. Journal of Biological Chemistry. 290(30). 18596–18608. 30 indexed citations

16.

Mo, Pingli, Qiling Zhou, Li Guan, et al.. (2014). Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene. 34(30). 3935–3945. 27 indexed citations

17.

Liu, Yonghong, Zhangwei Tong, Ting Li, et al.. (2012). Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness. Hepatology. 56(3). 1015–1024. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact